生物技术的尽职调查
大家好，
I come from a life sciences background and I wanted to get input from people in the world of finance.
会提供的公司affordable(3-4K USD) and表示(takes max 2-3 weeks to complete) scientific (technology, preclinical, clinical, IP, market size, management) due diligence reports on publicly traded early-stage biotech companies be of interest to investors and financial actors? Or are there alternatives that are satisfactory? Is the market saturated with these types of service providers?
Thank you!
Comments (2)
一般而言，没有生命科学咨询公司，生命科学公司公司，当然还有卖方分析师基本上已经在说什么。这种材料的市场非常非常饱和，因此我会说这将很难获得任何有意义的份额。
Commoci Id Beatae Aut Enim Quos。cupidates Eliquid Sit delectus。Quis Architecto recusandae fugiat qui unde dolorem。similique ab laudantium voluptates voluptate dolor qui unde。
Et non at delectus suscipit quas beatae aperiam minus. Fugiat sed ipsum distinctio sapiente et sapiente eum. Voluptatem officia minus aut velit expedita quo perspiciatis accusantium.
Optio et cum optio. Aut ea beatae sed voluptates. Sint voluptate voluptatibus temporibus ea. Aut distinctio eum sit eligendi.
查看所有评论 - 100％免费
WSO取决于每个人都知道某事时能够参与进来。解锁您的电子邮件并获得奖金：6 financial modeling lessons free($199 value)
orWant toUnlock通过签署您的社交帐户？
Preview & download comment as image
You can download this screenshot as image or copy to clipboard using browser's context menu